Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteolysis-targeting chimeras (PROTACs) in cancer therapy. | Mol Cancer | 2022 | 35410300 | PubTator, text mining | PubMed |
| First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers. | Int J Mol Sci | 2022 | 35409311 | PubTator, text mining | PubMed |
| New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy. | Int J Mol Sci | 2022 | 35409248 | PubTator, text mining | PubMed |
| New and Emerging Targeted Therapies for Hidradenitis Suppurativa. | Int J Mol Sci | 2022 | 35409118 | PubTator, text mining | PubMed |
Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications. | Int J Mol Sci | 2022 | 35409008 | PubTator, text mining | PubMed |
| Progesterone and Inflammatory Response in the Oviduct during Physiological and Pathological Conditions. | Cells | 2022 | 35406639 | PubTator, text mining | PubMed |
| Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts. | Cancer Discov | 2022 | 35405016 | PubTator, text mining | PubMed |
| Construction of disease-specific cytokine profiles by associating disease genes with immune responses. | PLoS Comput Biol | 2022 | 35404985 | PubTator, text mining | PubMed |
| Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Noninflammatory Aortic Aneurysms. | Arthritis Rheumatol | 2022 | 35403833 | PubTator, text mining | PubMed |
| Interacting Effects of Sea Louse (Lepeophtheirus salmonis) Infection and Formalin-Killed Aeromonas salmonicida on Atlantic Salmon Skin Transcriptome. | Front Immunol | 2022 | 35401509 | PubTator, text mining | PubMed |
| Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis? | Thromb Res | 2022 | 35397313 | PubTator, text mining | PubMed |
| Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia. | Cell Death Discov | 2022 | 35396375 | PubTator, text mining | PubMed |
| The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms. | Mol Cancer Ther | 2022 | 35395091 | PubTator, text mining | PubMed |
| Targeted protein degradation: mechanisms, strategies and application. | Signal Transduct Target Ther | 2022 | 35379777 | PubTator, text mining | PubMed |
| Activities and Molecular Mechanisms of Diterpenes, Diterpenoids, and Their Derivatives in Rheumatoid Arthritis. | Evid Based Complement Alternat Med | 2022 | 35368757 | PubTator, text mining | PubMed |
| Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression. | J Immunother Cancer | 2022 | 35361727 | PubTator, text mining | PubMed |
| Modulation of Plasma Proteomic Profile by Regular Training in Male and Female Basketball Players: A Preliminary Study. | Front Physiol | 2022 | 35360242 | PubTator, text mining | PubMed |
| Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases. | Front Oncol | 2022 | 35359383 | PubTator, text mining | PubMed |
| Synthesis and cellular evaluation of click-chemistry probes to study the biological effects of alpha, beta-unsaturated carbonyls. | Redox Biol | 2022 | 35358849 | PubTator, text mining | PubMed |
| Targeting IRAK4 Signaling in PDAC: Turning the "Cold" Tumors to "Hot" Ones. | Gastroenterology | 2022 | 35358509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=44